These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 120422)

  • 21. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dissolved oxygen on Tc-99m methylene diphosphonate: concise communication.
    Coupal JJ; Kim EE; DeLand FH
    J Nucl Med; 1981 Feb; 22(2):153-6. PubMed ID: 6450824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
    Yang JS
    Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
    Singh A; Usher M
    J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
    Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
    J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.
    Simon MA; Kirchner PT
    J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
    Silberstein EB
    Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An audit of paediatric technetium-99m methylene diphosphonate bone scans.
    Fishwick NG; Krarup KC; Belton IP; Finlay DB
    Br J Radiol; 1994 Jun; 67(798):552-5. PubMed ID: 8032808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintigraphic detection of osteomyelitis with Tc-99m MDP and Ga-67 citrate: concise communication.
    Graham GD; Lundy MM; Frederick RJ; Hartshorne MF; Berger DE
    J Nucl Med; 1983 Nov; 24(11):1019-22. PubMed ID: 6226766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 24-Hour/4-hour ratio of technetium-99m methylene diphosphonate uptake in patients with bone metastases and degenerative bone changes.
    Israel O; Front D; Frenkel A; Kleinhaus U
    J Nucl Med; 1985 Mar; 26(3):237-40. PubMed ID: 3156220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What do we want from a bone-scanning agent?
    Fogelman I; Bessent RG
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of Tc-99m MDP bone scanning in the study of vascularized bone implants: concise communication.
    Dee P; Lambruschi PG; Hiebert JM
    J Nucl Med; 1981 Jun; 22(6):522-5. PubMed ID: 6453211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal scintigraphy with technetium diphosphonate in multiple myeloma--a comparison with skeletal x-ray.
    Lindström E; Lindström FD
    Acta Med Scand; 1980; 208(4):289-91. PubMed ID: 6449830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of bone-scanning agents in hepatoma.
    Desai AG; Schaffer B; Park CH
    Radiology; 1983 Oct; 149(1):292. PubMed ID: 6310684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.